Biogen (BIIB) Gross Margin (2009 - 2026)
Biogen (BIIB) recorded Gross Margin of 71.60% in Q2 2026, down 5.53 percentage points from 77.13% a year earlier and down 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Gross Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Gross Margin came in at 73.99% as of Jun 30, 2026, down 1.43 percentage points year-over-year; for FY2025, it was 75.69%, down 0.43 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -10.88 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 76.12% in FY2024 (+1.88 pp), 74.24% in FY2023 (-3.36 pp), 77.61% in FY2022 (-3.18 pp) and 80.79% in FY2021 (-5.78 pp).
- The Q2 2026 figure is the lowest quarterly Gross Margin since Q1 2022.
- On a year-over-year basis, Gross Margin rose in three of the last eight quarters, with an average year-over-year change of -0.70 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 3.24 percentage points in Q1 2024, against a drop of 12.03 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 73.32% (Q1 2026), 78.26% (Q4 2025) and 73.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Biogen | 37.52 Bn | 24.18 Bn | 1.96 Bn | 71.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.60% |
| Mar 31, 2026 | 73.32% |
| Dec 31, 2025 | 78.26% |
| Sep 30, 2025 | 73.39% |
| Jun 30, 2025 | 77.13% |
| Mar 31, 2025 | 74.11% |
| Dec 31, 2024 | 76.23% |
| Sep 30, 2024 | 74.10% |
| Jun 30, 2024 | 77.85% |
| Mar 31, 2024 | 76.33% |
| Dec 31, 2023 | 74.09% |
| Sep 30, 2023 | 73.93% |
| Jun 30, 2023 | 75.87% |
| Mar 31, 2023 | 73.09% |
| Dec 31, 2022 | 77.56% |
| Sep 30, 2022 | 81.28% |
| Jun 30, 2022 | 81.31% |
| Mar 31, 2022 | 70.22% |
| Dec 31, 2021 | 75.85% |
| Sep 30, 2021 | 81.58% |
API Access
Biogen Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();